Implementing strategies for reducing prescribing errors in general practices
Submitting Institution
University of NottinghamUnit of Assessment
Public Health, Health Services and Primary CareSummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Public Health and Health Services
Summary of the impact
Our research has: i) increased public and professional knowledge and
understanding of the
prevalence, nature and causes of prescribing errors in general practices;
ii) led the General
Medical Council to recommend improvements to GP education and training;
iii) led to the Royal
College of General Practitioners to revise its curriculum to increase the
emphasis on safe
prescribing; iv) led one of the major GP computer system suppliers to make
safety improvements;
v) identified an IT-based intervention that is effective at reducing
prescribing errors; vi) led to the
roll-out of the intervention in over 800 general practices.
Underpinning research
The PRACtICe study (2010-11)[1,2,3] has provided much-needed evidence on
the prevalence and
causes of prescribing errors in general practices, while the PINCER trial
(2006-10)[4] has
demonstrated an effective method for reducing the prevalence of errors.
The aim of the PRACtICE study was to determine the prevalence and nature
of prescribing errors
in general practice; to explore the causes, and to identify defences
against error. The methods
included: 1) Two systematic reviews; 2) Retrospective review of unique
medication items
prescribed over a 12 month period to a 2% random sample of patients from
15 general practices in
England; 3) Interviews with 34 prescribers and six focus groups involving
46 primary health care
team members.
The study involved examination of 6,048 unique prescription items for
1,767 patients. Prescribing
or monitoring errors were detected in one in twenty of all prescription
items. The following factors
were associated with increased risk of prescribing or monitoring errors:
male gender, age less than
15 years or greater than 64 years, number of unique medication items
prescribed, and being
prescribed preparations in certain therapeutic areas.
A wide range of underlying causes of error was identified. In particular,
a lack of focus on
therapeutics and safe prescribing skills was highlighted in GP training,
and deficiencies were found
with the design of computerised prescribing systems in general practices.
Also, general practices
did not have reliable systems for detecting and correcting errors once
they had occurred.
A number of strategies were identified for reducing prescribing errors in
general practices and
these include improvements to GP training, improvements to GP computer
systems, and the
introduction of better systems for detecting and correcting errors (as
demonstrated in the PINCER
trial [4]).
The aim of the PINCER trial was to determine the effectiveness,
costs/benefits and acceptability of
a complex pharmacist-led IT-based intervention compared with simple
feedback in reducing rates
of prescribing and monitoring errors in general practice.
PINCER was a cluster randomised controlled trial which incorporated a
health economic analysis,
embedded longitudinal qualitative analysis, and process analysis of
pharmacists' interventions.
The control practices received computer-generated simple feedback for
patients at-risk of
hazardous prescribing. The intervention practices received feedback,
educational outreach and
dedicated support from a pharmacist.
Seventy-two practices were randomised. At 6 months follow-up, patients in
the intervention group
were up to 50% less likely to have one of a range of 10 prescribing or
monitoring errors. Economic
modelling showed that the PINCER intervention increased health gain at a
cost per QALY well
below the National Institute for Health and Care Excellence (NICE)
threshold.
University of Nottingham colleagues involved in the PINCER trial were
Tony Avery (chief
investigator) Sarah Rodgers (trial manager), Sarah Armstrong (trial
statistician), Denise Kendrick
and Rachel Elliott (health economist). Professor Avery also led the
PRACtICe study, and other
University of Nottingham colleagues involved were Sarah Armstrong and Raj
Mahta (statisticians).
The PINCER trial involved in the universities of Manchester and Edinburgh;
the PRACtICe study
involved University College London, and the universities of Hertfordshire
and Reading.
References to the research
This section should provide references to key outputs from the
research described in the previous
section, and evidence about the quality of the research.
1. Avery A, Barber N, Ghaleb M, Dean Franklin B, Sarah Armstrong S, Crowe
S, Dhillon S, Freyer
A, Howard R, Pezzolesi C, Serumaga B, Swanwick G, Talabi O. Investigating
the prevalence
and causes of prescribing errors in general practice: The PRACtICe Study
(PRevalence And
Causes of prescrIbing errors in general practiCe). London: General Medical
Council, 2012.
(259-page project report). Report available at: http://www.gmc-uk.org/about/research/12996.asp
(PDF Supplied)
2. Avery A, Ghaleb M, Barber N, Dean Franklin B, Sarah Armstrong S,
Serumaga B, Dhillon S,
Freyer A, Howard R, Talabi O, Mehta RL. The prevalence and nature of
prescribing and
monitoring errors in English general practice — a retrospective case note
review. British Journal
of General Practice 2013; 63( 613):e543-e553 doi: 10.3399/bjgp13X670679
(PDF Supplied)
3. Slight SP, Howard R, Ghaleb M, Barber N, Dean Franklin B, Avery AJ.
The causes of
prescribing errors in English general practices: a qualitative study.
British Journal of General
Practice 2013; Published online 30th September 2013: e713-e720
doi: 10.3399/bjgp13X673739 (PDF Supplied)
4. Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M,
Elliott RA, Howard R,
Kendrick D, Morris CJ, Prescott RJ, Swanwick G, Franklin M, Putman K, Boyd
M, Sheikh A. A
pharmacist-led information technology intervention for medication errors
(PINCER): a
multicentre, cluster randomised, controlled trial and cost-effectiveness
analysis. The Lancet
2012; 379(9823): 1310-1319 doi:10.1016/S0140-6736(11)61817-5 (PDF
Supplied)
Details of grants:
The grant for the PINCER trial was awarded to Professor Avery, University
of Nottingham.
The grant title was: Cluster randomised trial evaluating the
effectiveness of a pharmacist-led
intervention vs. simple feedback in reducing rates of hazardous
prescribing in general practices
(The PINCER Trial).
The funder of the study was the Department of Health.
The period of the grant was 2006-2010.
The value of the grant was £643,690.
The grant for the PRACtICE study was awarded to Professor Avery,
University of Nottingham.
The grant title was: Investigating the prevalence and causes of
prescribing errors in general
practice.
The funder of the study was the General Medical Council (GMC).
The period of the grant was January 2010-October 2011.
The value of the grant was £101,380.
Details of the impact
The PRACtICe study has provided the best evidence to date on prevalence,
nature and causes of
prescribing errors in general practices whilst the PINCER trial has
identified a highly successful
intervention to reduce prescribing errors in primary care. The main
evidence of impact comes from
media coverage, changes to the RCGP curriculum, production of learning
materials for GPs,
developments to the TPP SystmOne GP computer system, and uptake from a
release of computer
queries used in the PINCER trial. These have all occurred in 2012-13. The
main beneficiaries are
patients and members of the public, GPs, pharmacists and the NHS.
Our report on the GMC-funded PRACtICe study was launched at a press
conference at the
Wellcome Trust in May 2012. The study findings received substantial media
interest [A] including
front-page headlines in The Daily Telegraph and The Daily
Express; articles in all major national
newspapers; Professor Avery being interviewed on the BBC Radio 4 Today
Programme and BBC
Radio 2 Jeremy Vine show; and coverage on several hundred radio
stations and several hundred
websites. This raised public awareness and debate around the problems of
prescribing errors in
general practice and interviews undertaken by Professors Avery helped
improve public
understanding of the issue. In an article for the Daily Mail,
Professor Avery explained how patients
can help reduce their chances of having a prescribing error. As a result
of this publicity, the BBC1
Inside-Out programme commissioned and produced a documentary on
prescribing errors in
primary care which included Professor Avery explaining the findings from
the PRACtICe study.
This was broadcast in three regions of England in October and November
2012.
As a result of the publication of the PRACtICE study report, Peter Rubin
(President of the GMC)
confirmed that in 2012/13, "We [the GMC] have met with relevant
organisations to ensure that the
findings [of the study] around a greater role for pharmacists in
supporting GPs, the better use of
computer systems and the extra emphasis on prescribing in GP training
are translated into actions
that help protect patients." [B] Professor Avery has worked closely
with the RCGP since the
publication of the report and presented findings and recommendations at an
RCGP Curriculum
Group meeting in June 2012, and the RCGP National Conference in October
2012. The following
impacts have resulted from this [C]: 1) Additional learning outcomes on
therapeutics and safe
prescribing skills, written by Professor Avery and ratified by the GMC,
were added to the 2013
RCGP curriculum [D]; 2) Following a meeting between Professor Avery and
RCGP examiners in
April 2013, assessment of therapeutics and safe prescribing has been
strengthened in the MRCGP
examination, e.g. new consultation skills assessments have been developed.
The PRACtICE study report suggested various ways in which the prescribing
safety features of
general practice computer systems could be improved. In August 2012, the
GP periodical Pulse
reported that TPP SystmOne, "one of the country's biggest GP software
providers has
implemented a raft of changes to almost 2,000 practice systems in the wake
of a GMC-funded
study which estimated there are errors in 1 in 20 GP prescriptions
nationally" [E]. This has included
computerised alerts aimed at ensuring that patients on high-risk drugs
receive necessary blood-tests.
As a result of the publication of the PINCER trial in The Lancet,
general practice organisations and
NHS leaders (including the Chief Pharmaceutical Officer) have expressed
considerable interest in
rolling out the intervention to general practices in England. Since 2012,
Professor Avery and
colleagues have worked with a University spin out company (PRIMIS) to
produce e-learning
materials [F] and develop new methods for general practices to download
computer queries used
in the PINCER trial [G] to identify prescribing errors and prevent patient
harm. By July 2013, over
800 general practices had downloaded these computer queries [H] with
potential benefits to
thousands of patients, and the NHS, from this cost-effective intervention.
Keith Ridge, the Chief Pharmaceutical Officer, stated in 2013 that the
PRACtICe Study, "has
brought considerable, and much-needed, recognition of ... the problem of
prescribing errors ... in
general practice" and that he "and other senior Government and
NHS officials and professionals,
routinely use this study as justification for policy development and
initiatives designed to improve
quality and outcome for patients." [I] He also stated that PINCER is
"an important step towards
improving patient safety and outcomes from medicines prescribing and
use, including the
development of IT to support clinical decisions." [I]
Sources to corroborate the impact
Sources to corroborate the impact include:
A. An electronic file summarising the impact of the study in the media,
providing newspaper
clippings and details of the study being included in print media, online
and on the radio; and
audiofiles of Professor Avery being interviewed on BBC Radio 2 and Radio
4.
B. Letter from President of the GMC, on the impact of the PRACtICe study
on their policies*.
C. Letter from Chair of College Council, RCGP, on the impact of the
PRACtICe study on changes
to the RCGP curriculum, development of electronic learning materials, and
changes to MRCGP
examinations*.
D. Details of changes to the RCGP Curriculum specifically made as a
result of the
recommendations arising from our GMC-funded report.
E. Evidence presented in Pulse detailing the changes made to the
TPP SystmOne GP computer
systems specifically attributed to the findings of the GMC-funded report:
http://www.pulsetoday.co.uk/tpp-upgrades-practice-systems-in-wake-of-gmc-prescribing-error-report/14447023.article
(PDF supplied)
F. eLearning materials developed as a result of the PINCER study:
http://www.pulse-learning.co.uk/commissioning-modules/commissioning/how-we-reduced-prescribing-errors-with-pharmacists-support
(PDF/Screenshot provided)
G. Details showing how general practices can download the computer
queries used in the
PINCER trial:
a. Rodgers S. New PINCER Query Library Tool to support safer prescribing,
Prescriber
2013; 24(6): 11-14 (19 March 2013) DOI: 10.1002/psb.1027
http://onlinelibrary.wiley.com/doi/10.1002/psb.1027/pdf
(PDF Supplied)
b. Rodgers S. Five steps to reducing prescribing errors using PINCER.
Pulse Today 12
February 2013 http://www.pulsetoday.co.uk/your-practice/practice-topics/it/-five-steps-to-reducing-prescribing-errors-using-pincer/20001835.article
(PDF supplied)
H. Log from PRIMIS showing the number and distribution of general
practices downloading the
PINCER trial computer queries in the first 8 weeks plus cumulative data
showing the number of
downloads for February — July 2013.
I. Letter from Chief Pharmaceutical Officer, Department of Health,
England, on the impact of the
PRACtICe study and PINCER trial*. Minutes from RCGP Curriculum Group
meeting 15 June
2012 outlining actions to be taken as a result of the recommendations
arising from the
PRACtICe study report.
*Corroborative factual statements — letters are on file and available on
request.